Study Progresses to Fourth Higher 90 mg/m2 Dose Cohort Compelling Patient Response Highlighted by Stable Disease and Significant Reduction in Blast Count After One Treatment Cycle HOUSTON, Feb. 12, ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Texas universities could lose hundreds of millions of dollars in federal funds that support medical research if a Trump ...

The NIH on Friday announced a new policy that limits so-called “indirect costs,” which Houston institutions depend on to ...

Dr. Brewer will see patients at the PeaceHealth Squalicum Parkway Obstetrics, Gynecology and Midwifery Clinic at 3200 ...

A federal judge blocked a new National Institutes of Health policy from going into effect in 22 states that sued the agency, ...

A DAD has battled four brain tumours across 14 years and a bizarre food craving alerted him to it. Dan Horrocks, 33, was diagnosed with his first life-threatening tumour in August 2011, which led ...

The dad-of-one from London, UK noticed one particularly strange occurence before he received his devastating diagnosis ...

A dad who has battled four brain tumors – discovering one after developing a craving for olives – is raising $50,000 for ...

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could unlock safer and more effective cancer treatments, according to Virginia Tech ...